<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03590548</url>
  </required_header>
  <id_info>
    <org_study_id>egypt AssiutU</org_study_id>
    <nct_id>NCT03590548</nct_id>
  </id_info>
  <brief_title>Clinical Audit of Managment of Gausher Disease in Children</brief_title>
  <official_title>Assiut University Children 's Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yasmeen Abd Elbaset Hamzaa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      clinical audit on managment of gausher disease in children
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main aim of study is to evaluate the management of Gausher disease patient under enzyme
      replacement therapy in Assuit University Children's Hospital and compare our policy for
      management with International guideline of management of Gausher disease in children (8)

        -  Type of study : clinical audit

        -  Inclusion criteria: All cases with confirmed diagnosis of Gaucher disease type 1 and
           type 3 receiving enzyme replacement therapy at Assuit University Children's Hospital.

        -  Site of study :Assuit University children's Hospital Methodiological

        -  Exclusion criteria 3-New diagnosed cases not on ERT. 2-other lipid storage disease.

        -  Patient&amp; method The study will include 42 diagnosed Gaucher disease patient under enzyme
           replacement therapy attend the hematology unit in Assuit University Children's Hospital
           in one year Reviewing the proposal will be carried out before starting via the ethical
           committee of Assuit Faculty of Medicine.

        -  Ethical consideration The aim of the study will be explained to each patient before
           beginning of the process.

      We will compare our policy in management of Gausher disease with International guideline of
      management of gausher disease

      1-cases of Gaucher type 2.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">July 2018</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>evaluate the management of Gausher disease patient under enzyme replacement therapy in Assuit University Children's Hospital and compare our policy for management with International guideline of management of Gausher disease in children (8)</measure>
    <time_frame>one year</time_frame>
    <description>• Type of study : clinical audit</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1</enrollment>
  <condition>Gaucher Disease</condition>
  <arm_group>
    <arm_group_label>gausher disease in children</arm_group_label>
    <description>• Inclusion criteria: All cases with confirmed diagnosis of Gaucher disease type 1 and type 3 receiving enzyme replacement therapy at Assuit University Children's Hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>gausher disease</intervention_name>
    <description>lab investigation and radio logical</description>
    <arm_group_label>gausher disease in children</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will include 42 diagnosed Gaucher disease patient under enzyme replacement
        therapy attend the hematology unit in Assuit University Children's Hospital in one year
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All cases with confirmed diagnosis of Gaucher disease type 1 and type 3 receiving
             enzyme replacement therapy at Assuit University Children's Hospital.

        Exclusion Criteria:

          -  1-cases of Gaucher type 2. 2-other lipid storage disease. 3-New diagnosed cases not on
             ERT.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mervit Amin, doctora</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut unversity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>yasmeen hamzaa, graduted</last_name>
    <phone>01121912793</phone>
    <email>Yasmeenhamzaa88@gmail.com</email>
  </overall_contact>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 7, 2018</study_first_submitted>
  <study_first_submitted_qc>July 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2018</study_first_posted>
  <last_update_submitted>July 7, 2018</last_update_submitted>
  <last_update_submitted_qc>July 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Yasmeen Abd Elbaset Hamzaa</investigator_full_name>
    <investigator_title>Assiut University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gaucher Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

